High levels of maternally derived RSV-neutralizing antibodies correlate with a decreased risk of infection and hospitalization in newborn infants. G protein is a 90-kDa, highly glycosylated ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

More information: Michael G Ison et al, Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over ...

Currently, three approved vaccines against this virus are available: the adjuvanted RSV prefusion F protein-based vaccine ... limited subgroup analyses (e.g., by frailty). The study measured ...

The trimeric pre-fusion glycoprotein F is essential for accurately assessing the immunogenicity of RSV vaccines. We strictly adhere to regulations to provide high-quality, consistent, native ...

The inventors have created a reverse genetics system for RSV strain B1 of antigenic ... contains a codon-optimized G ORF and expresses enhanced green fluorescence protein (GFP).